FREnch Survey on Heart Failure
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,719
- 试验地点
- 1
- 主要终点
- Mortality at one-year of follow-up
研究概览
简要总结
Heart failure is the most common heart disease with increasing incidence due to the aging of the population is improving the initial prognosis of various conditions that lead to more or less progressive heart failure.
Heart failure is of great variety of clinical and pathophysiological forms necessitating the creation of quality records to clarify each of these forms.
Many types of cardiomyopathies exist, some of which are infrequent but with specific care.
At the French level, few data exist. In addition, the therapeutic management changes regularly.
New European recommendations (endorsed by the French Society of Cardiology = FSC) were published in May 2012. Many therapeutic approaches are being evaluated. The course of care and how to take non-drug load (network monitoring, rehabilitation ...) have become important issues that have hardly been analyzed by existing records.
This also leads to better define the different forms of this disease, their natural history and methods of management applied in real life. The register of FSC follows the registry of the European Society of Cardiology (ESC)"Heart Failure (HF) Long Term" (CCTIRS No. 11.355bis) with inclusions will be completed in November 2012. This new study aims to generate more accurate data on a number of points and be more representative for a wider selection of patients, the French level.
详细描述
The recruitment period will be 24 months, with a day of inclusion for each week, which will be included both patients external consultant for chronic heart failure patients hospitalized in the cardiology department, during this day for acute heart failure.
Monitoring will be carried out 12 months during a consultation normally scheduled for this type of pathology with the cardiologist investigator. Patients included in a decompensation will also follow up to 3 months
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patient with chronic HF OR patient hospitalized foor acute HF de novo or not
- •patient who accept to participate by signing a informed consent
排除标准
- •patient who deny to participate
结局指标
主要结局
Mortality at one-year of follow-up
时间窗: 12 months
Death rate at 12 months of follow-up
次要结局
- Morbidity at one year of follow-up(12 months)
